Genomic profiling of Richter's syndrome: Recurrent lesions and differences with de novo diffuse large B-cell lymphomas

Hematological Oncology

Volumn 28, Issue 2, 2010, Pages 62-67

  Scandurra, Marta ^a   Rossi, Davide ^b   Deambrogi, Clara ^b   Rancoita, Paola M V ^a,c   Chigrinova, Ekaterina ^a   Mian, Michael ^a,d   Cerri, Michaela ^b   Rasi, Silvia ^b   Sozzi, Elisa ^e   Forconi, Francesco ^e   Ponzoni, Maurilio ^f   Moreno, Santiago M ^g   Piris, Miguel A ^g   Inghirami, Giorgio ^h   Zucca, Emanuele ^a   Gattei, Valter ⁱ   Rinaldi, Andrea ^a   Kwee, Ivo ^a,c   Gaidano, Gianluca ^b   Bertoni, Francesco ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c DALLE MOLLE INSTITUTE FOR ARTIFICIAL INTELLIGENCE IDSIA   (Switzerland)

^d Azienda Ospedaliera S Maurizio   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g Centro Nacional de Investigaciones Oncológicas   (Spain)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

13q; 8q; Affymetrix; Chronic lymphocytic leukaemia; Lymphoma; MIRHG1; MYC

Indexed keywords

GENOMIC DNA; MICRORNA; PROTEIN P53;

ARTICLE; CHROMOSOME 13Q; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DNA FINGERPRINTING; FEMALE; GENE TRANSLOCATION; GENETIC TRANSFORMATION; HUMAN; LARGE CELL LYMPHOMA; MALE; MUTATION; ONCOGENE C MYC; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RICHTER SYNDROME;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 6; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE REARRANGEMENT, B-LYMPHOCYTE; GENES, MYC; GENES, P53; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICRORNAS; NUCLEAR PROTEINS; PHENOTYPE; RECURRENCE; REPRESSOR PROTEINS; SEQUENCE DELETION; SYNDROME;

EID: 77953263477     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.932     Document Type: Article

References (32)

1. Tsimberidou AM, Keating MJ. Richter syndrome: biology, incidence, and therapeutic strategies. Cancer 2005; 103: 216-228.
2. Rossi D, Gaidano G. Richter syndrome: molecular insights and clinical perspectives. Hematol Oncol 2009; 27: 1-10.
3. Aydin S, Rossi D, Bergui L, et al. CD38 gene polymorphism and chronic lymphocytic leukemia: A role in transformation to Richter's syndrome? Blood 2008; 111: 5646-5653.
4. Bea S, Lopez-Guillermo A, Ribas M, et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am J Pathol 2002; 161: 957-968. (Pubitemid 34988383)
5. Cotter FE, Auer RL. Genetic alteration associated with chronic lymphocytic leukemia. Cytogenet Genome Res 2007; 118: 310-319.
6. Gaidano G, Ballerini P, Gong JZ, et al. p53 Mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413-5417. (Pubitemid 21914755)
7. Reiniger L, Bodor C, Bognar A, et al. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia 2006; 20: 1089-1095.
8. Rossi D, Berra E, Cerri M, et al. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica 2006; 91: 1405-1409. (Pubitemid 44569818)
9. Deambrogi C, Cresta S, Cerri M, et al. 14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia. Br J Haematol 2009; 144: 131-133.
10. Rossi D, Cerri M, Deambrogi C, et al. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. Clin Cancer Res 2009; 15: 995-1004.
11. Rossi D, Spina V, Cerri M, et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter's syndrome. Clin Cancer Res 2009 Jul 1; 15(13): 4415-4422.
12. Rossi D, Lobetti Bodoni C, Genuardi E, et al. Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. Leukemia 2009; 23: 1062-1072.
13. Rossi D, Cerri M, Capello D, et al. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 2008; 142: 202-215.
14. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R. p53 Mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289-2295.
15. Matolcsy A, Inghirami G, Knowles DM. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 1994; 83: 1363-1372. (Pubitemid 24062860)
16. Nakamura N, Abe M. Richter syndrome in B-cell chronic lymphocytic leukemia. Pathol Int 2003; 53: 195-203.
17. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341-346.
18. Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-1645. (Pubitemid 24323778)
19. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-282.
20. Capello D, Scandurra M, Poretti G, et al. Genome wide DNA-profiling of HIV-related B-cell lymphomas. Br J Haematol 2009 Oct 12. [Epub ahead of print]; PMD: 19832807.
21. Rancoita PMV, Hutter M, Bertoni F, Kwee I. Bayesian DNA copy number analysis. BMC Bioinf 2009; 10: 10.
22. Beroukhim R, Lin M, Park Y, et al. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol 2006; 2: 41.
23. Lenz G, Wright GW, Emre NC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008; 105: 13520.
24. Schwaenen C, Viardot A, Berger H, et al. Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer 2009; 48: 39-54.
25. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-833.
26. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009; 136: 26-36.
27. Mao Z, Quintanilla-Martinez L, Raffeld M, et al. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (BCLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 2007; 31: 1605-1614.
28. Pasqualucci L, Compagno M, Houldsworth J, et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 2006; 203: 311-317.
29. Chen W, Houldsworth J, Olshen AB, et al. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood 2006; 107: 2477-2485.
30. Tagawa H, Tsuzuki S, Suzuki R, et al. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases. Cancer Res 2004; 64: 5948-5955.
31. Compagno M, Lim WK, Grunn A, et al. Mutations at multiple genes cause deregulation of the NF-κB pathway in diffuse large B-cell lymphoma. Nature 2009; 459: 717-721.
32. Cheung KJ, Shah SP, Steidl C, et al. Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significantDNA copy number imbalances. Blood 2009; 113: 137-148.